The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Marciniak, Elodie ^a,b,c   Faivre, Emilie ^a,b,c   Dutar, Patrick ^d   Alves Pires, Claire ^a,b,c   Demeyer, Dominique ^a,b,c   Caillierez, Raphaëlle ^a,b,c   Laloux, Charlotte ^a   Buée, Luc ^a,b,c   Blum, David ^a,b,c   Humez, Sandrine ^a,b,c  

^a UNIV LILLE   (France)

^b JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CCL3 PROTEIN, MOUSE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;

ANIMAL; DRUG EFFECTS; HIPPOCAMPUS; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MALE; MEMORY; METABOLISM; MOUSE; SYNAPTIC TRANSMISSION;

ANIMALS; CHEMOKINE CCL3; HIPPOCAMPUS; LONG-TERM POTENTIATION; LONG-TERM SYNAPTIC DEPRESSION; MALE; MEMORY; MICE; NEUROTRANSMITTER AGENTS; SYNAPTIC TRANSMISSION;

EID: 84946148855     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15862     Document Type: Article

References (60)

1. Yirmiya, R. & Goshen, I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 25, 181-213 (2011)
2. Donzis, E. J. & Tronson, N. C. Modulation of learning and memory by cytokines: signaling mechanisms and long-term consequences. Neurobiol. Learn. Mem. 115, 68-77 (2014)
3. Coogan, A. N., ONeill, L. A. & OConnor, J. J. The P38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1? on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience 93, 57-69 (1999)
4. Avital, A. et al. Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus 13, 826-834 (2003)
5. Moore, A. H., Wu, M., Shaftel, S. S., Graham, K. A. & OBanion, M. K. Sustained expression of interleukin-1beta in mouse hippocampus impairs spatial memory. Neuroscience. 164, 1484-1495 (2009)
6. Hein, A. M. et al. Sustained hippocampal IL-1? overexpression impairs contextual and spatial memory in transgenic mice. Brain Behav. Immun. 24, 243-253 (2010)
7. Lynch, M. A. Neuroinflammatory changes negatively impact on LTP: A focus on IL-1? . Brain Res. doi: org/10. 1016/j. brainres. 2014. 08. 040 (2014)
8. Reaux-Le Goazigo, A., Van Steenwinckel, J., Rostene, W. & Melik Parsadaniantz, S. Current status of chemokines in the adult CNS. Prog. Neurobiol. 104, 67-92 (2013)
9. Cartier, L., Hartley, O., Dubois-Dauphin, M. & Krause, K. H. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Brain Res. Rev. 48, 16-42 (2005)
10. Liu, C., Cui, G., Zhu, M., Kang, X. & Guo, H. Neuroinflammation in Alzheimers disease: chemokines produced by astrocytes and chemokine receptors. Int. J. Clin. Exp. Pathol. 7, 8342-8355 (2014)
11. Borroni, E. M., Mantovani, A., Locati, M. & Bonecchi, R. Chemokine receptors intracellular trafficking. Pharmacol. Ther. 127, 1-8 (2010)
12. Sharma, M. Chemokines and their receptors: orchestrating a fine balance between health and disease. Crit. Rev. Biotechnol. 30, 1-22 (2010)
13. Banisadr, G., Rostene, W., Kitabgi, P. & Parsadaniantz, S. M. Chemokines and brain functions. Curr. Drug Targets Inflamm. Allergy 4, 387-399 (2005)
14. Rostene, W. et al. Chemokines and chemokine receptors: new actors in neuroendocrine regulations. Front. Neuroendocrinol. 32, 10-24 (2011)
15. Rostene, W. et al. Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system. J. neurochem. 118, 680-694 (2011)
16. Guyon, A. & Nahon, J. L. Multiple actions of the chemokine stromal cell-derived factor-1? on neuronal activity. J. Mol. Endocrinol. 38, 365-376 (2007)
17. Zhou, Y., Tang, H., Liu, J., Dong, J. & Xiong, H. Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices. J. Neurochem. 116, 406-414 (2011)
18. Maggi, L. et al. LTP impairment by fractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R). J. Neuroimmunol. 215, 36-42 (2009)
19. Sheridan, G. K. et al. CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity. Front. Cell Neurosci. 8, 233 (2014)
20. Williamson, L. L. & Bilbo, S. D. Chemokines and the hippocampus: a new perspective on hippocampal plasticity and vulnerability. Brain Behav. Immun. 30, 186-94 (2013)
21. Zhu, X. B. et al. Characterization of the expression of macrophage inflammatory protein-1? (MIP-1? ) and C-C chemokine receptor 5 (CCR5) after kainic acid-induced status epilepticus (SE) in juvenile rats. Neuropathol. Appl. Neurobiol. 38, 602-616 (2012)
22. Xu, J. H. et al. CCR3, CCR2A and macrophage inflammatory protein (MIP)-1? , monocyte chemotactic protein-1 (MCP-1) in the mouse hippocampus during and after pilocarpine-induced status epilepticus (PISE). Neuropathol. Appl. Neurobiol. 35, 496-514 (2009)
23. Galasso, J. M., Harrison, J. K. & Silverstein, F. S. Excitotoxic brain injury stimulates expression of the chemokine receptor CCR5 in neonatal rats. Am. J. Pathol. 153, 1631-1640 (1998)
24. Mennicken, F., Chabot, J. G. & Quirion, R., 2002. Systemic administration of kainic acid in adult rat stimulates expression of the chemokine receptor CCR5 in the forebrain. Glia 37, 124-138 (2002)
25. Meucci, O. et al. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA 95, 14500-14505 (1998)
26. Lee, T. S. et al. Gene expression in temporal lobe epilepsy is consistent with increased release of glutamate by astrocytes. Mol. Med. 13, 1-13 (2007)
27. Guzik-Kornacka, A., Sliwa, A., Plucinska, G. & Lukasiuk, K. Status epilepticus evokes prolonged increase in the expression of CCL3 and CCL4 mRNA and protein in the rat brain. Acta Neurobiol Exp. 71, 193-207 (2011)
28. Johnson, E. A. et al. Increased expression of the chemokines CXCL1 and MIP-1? by resident brain cells precedes neutrophil infiltration in the brain following prolonged soman-induced status epilepticus in rats. J. Neuroinflammation 8, 41-51 (2011)
29. Geppert, A. M., Losy, J., Przedpelska-Ober, E. & Kozubski, W. CCL3 correlates with the number of mood disturbances and personality changes in patients with Alzheimers disease. Psychiatry Res. 176, 261-264 (2010)
30. Xia, M. Q., Qin, S. X., Wu, L. J., Mackay, C. R. & Hyman, B. T. Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimers disease brains. Am. J. Pathol. 153, 31-37 (1998)
31. Song, M. et al. TLR4 mutation reduces microglial activation, increases A? deposits and exacerbates cognitive deficits in a mouse model of Alzheimers disease. J. Neuroinflammation 8, 92 (2011)
32. Garwood, C. J., Cooper, J. D., Hanger, D. P. & Noble, W. Anti-inflammatory impact of minocycline in a mouse model of tauopathy. Front. Psychiatry. 12, 1:136 (2010)
33. Laurent, C. et al. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Mol. Psychiatry doi: 10. 1038/ mp. 2014. 151 (2014)
34. Li, K. et al. Association between the macrophage inflammatory protein-l alpha gene polymorphism and Alzheimers disease in the Chinese population. Neurosci. Lett. 433, 125-128 (2008)
35. Flex, A. et al. Effect of proinflammatory gene polymorphisms on the risk of Alzheimers disease. Neurodegener. Dis. 13, 230-236 (2014)
36. Cudaback, E., Yang, Y., Montine, T. J. & Keene C. D. APOE genotype-dependent modulation of astrocyte chemokine CCL3 production. Glia 63, 51-65 (2015)
37. Kuijpers, M., Van Gassen, K. L., De Graan, P. N. & Gruol, D. Chronic exposure to the chemokine CCL3 enhances neuronal network activity in rat hippocampal cultures. J. Neuroimmunol. 229, 73-80 (2010)
38. Nelson, T. E. E. et al. Altered synaptic transmission in the hippocampus of transgenic mice with enhanced central nervous systems expression of interleukin-6. Brain Behav Immun. 26, 959-71 (2012)
39. Banisadr, G. et al. The chemokine BRAK/CXCL14 regulates synaptic transmission in the adult mouse dentate gyrus stem cell niche. J. Neurochem. 119, 1173-1182 (2011)
40. Giovannelli, A. et al. CXC chemokines interleukin-8 (IL-8) and growth-related gene product ? (GRO? ) modulate Purkinje neuron activity in mouse cerebellum. J Neuroimmunol. 92, 122-132 (1998)
41. Guyon, A. et al. Stromal cell-derived factor-1? modulation of the excitability of rat substantia nigra dopaminergic neurones: presynaptic mechanisms. J. Neurochem. 96, 1540-1550 (2006)
42. Guyon, A. et al. Long-term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. Neuroscience 162, 1072-1080 (2009)
43. Citri, A. & Malenka, R. C. Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology 33, 18-41 (2008)
44. Collingridge, G. L., Peineau, S., Howland, J. G. & Wang, Y. T. Long-term depression in the CNS. Nat. Rev. Neurosci. 11, 459-73 (2010)
45. Louboutin, J. P., Chekmasova, A., Marusich, E., Agrawal, L. & Strayer, D. S. Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage. FASEB J. 25, 737-753 (2011)
46. Kan, A. A. et al. Prolonged increase in rat hippocampal chemokine signalling after status epilepticus. J Neuroimmunol. 245, 15-22 (2012)
47. Szabo, I. et al. J. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc. Natl. Acad. Sci. USA 99, 10276-10281 (2002)
48. Musante, V. et al. RANTES modulates the release of glutamate in human neocortex J. Neurosci. 28, 12231-12240 (2008).
49. Laurent, C. et al. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Mol Psychiatry. doi: 10. 1038/ mp. 2015. 115 (2015)
50. Brouillette, J. et al. Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-? 1-42 oligomers are revealed in vivo by using a novel animal model. J. Neurosci. 32, 7852-61 (2012)
51. Whitlock, J. R., Heynen, A. J., Shuler, M. G. & Bear, M. F. Learning induces long-term potentiation in the hippocampus. Science. 313, 1093-7 (2006)
52. Mitsushima, D., Ishihara, K., Sano, A., Kessels, H. W. & Takahashi, T. Contextual learning requires synaptic AMPA receptor delivery in the hippocampus. Proc Natl Acad Sci USA. 108, 12503-8 (2011)
53. Van der Jeugd, A. et al. Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau. Acta Neuropathol. 123, 787-805 (2012)
54. Kalkonde, Y. V. et al. The CC chemokine receptor 5 regulates olfactory and social recognition in mice. Neuroscience 197, 153-161(2011)
55. Passos, G. F. et al. Role of the macrophage inflammatory protein-1? /CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by ? -amyloid peptide. Am. J. Pathol. 175, 1586-1597 (2009)
56. Lee, Y. K. et al. CCR5 deficiency induces astrocyte activation, A? deposit and impaired memory function. Neurobiology of learning and memory 92, 356-363 (2009)
57. Maung, R. et al. CCR5 knockout prevehnts neuronal injury and behavioral impariment induced in a transgenic mouse model by a CXCR4-using HIV-1 glycoprotein 120. The journal of immunology. 193, 1895-1910 (2014)
58. Perea, G. & Araque, A. GLIA modulates synaptic transmission. Brain research reviews. 63, 93-102 (2010)
59. De Pitta, M., Brunel, N. & Volterra, A. Astrocytes : orchestrating synaptic plasticity? Neuroscience (2015) doi: 10. 1016/j. neuroscience. 2015. 04. 001
60. Fields, R. D. et al. Glial biology in learning and cognition. The neuroscientist. 20, 426-431 (2014)